Results 131 to 140 of about 45,302 (241)

Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations

open access: yes, 2016
Suganthini Krishnan Natesan,1,2 Pranatharthi H Chandrasekar1 1Division of Infectious Diseases, Department of Internal Medicine, Wayne State University, 2John D Dingell VA Medical Center, Detroit, MI, USA Abstract: The majority of invasive mold infections
Chandrasekar PH, Natesan SK
core  

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Aspergillosis, brain

open access: yes, 1997
Aspergillosis, brain. A 45-85. Coronal plane.

core  

CLINICAL CHARACTERIZATION OF THE MAXILLARY SINUS ASPERGILLOSIS [PDF]

open access: yes, 2001
Nine cases of maxillary sinus aspergillosis during a period from February of 1992 to June of 2000 were investigated to analyze the clinical, radiologic and pathologic features. Maxillary sinus aspergillosis is rare disease, but it was increasing tendency
김형준, 차인호
core  

Itracoanzole in human aspergillosis revisited.

open access: yes, 2004
Itraconazole is a broad spectrum antifungal agent of the bis-triazole class. The drug is an important option in the management of many human mycoses including various clinical presentations of aspergillosis.
Kharfi, M.   +4 more
core  

Pathological Diagnosis of Pulmonary Aspergillosis

open access: yes
Pulmonary aspergillosis constitutes an increasingly prevalent and potentially fatal complex of mycotic diseases, caused by different species of Aspergillus.
Jensen, Henrik E., Becker, Cecilie B.
core   +1 more source

Disseminated aspergillosis [PDF]

open access: yesThorax, 1970
B J, Burke, F K, Storring, T E, Parry
openaire   +2 more sources

Home - About - Disclaimer - Privacy